3 H]spiperone in the absence of sodium ions raclopride exerted noncompetitive effects, decreasing the number of sites labeled by the radioligand. These data are interpreted in terms of a model where the receptor exists as a dimer, and in the absence of sodium ions, raclopride exerts negative cooperativity across the dimer both for its own binding and the binding of spiperone. A model of the receptor has been produced that provides a good description of the experimental phenomena described here.
The G-protein-coupled receptors (GPCRs) 1 constitute a large family of proteins responsible for the transduction of a wide range of signals (e.g. hormones, neurotransmitters, odorants, light, etc.) via G-proteins (1) . GPCRs possess a common structural motif of seven ␣-helical membrane-spanning domains, and it is often assumed that the functional unit (i.e. the ligand binding and G-protein interaction domains) of the GPCR is wholly contained in a single polypeptide. Indeed, most models of GPCR function assume a monomeric receptor interacting with the G-protein (see, for example, Ref. 2) . Several lines of evidence, however, suggest that the some GPCRs may exist in dimeric or oligomeric forms.
Immunoblotting has in several cases revealed species corresponding not only to the predicted molecular weight of the receptor but also to multiples of the molecular weight. Bands corresponding to approximately twice the predicted molecular weight of the receptor have been interpreted as homodimers for several receptors including D 2 dopamine (3, 4) , D 3 dopamine (5), ␤ 2 -adrenergic (6), substance P (7), opiate (8) and M 1 and M 2 muscarinic acetylcholine receptors (9) . Co-immunoprecipitation has also been used to demonstrate homodimer formation for the ␤ 2 -adrenergic receptor (6) , opiate receptor (8) , and somatostatin SSTR5 receptor (10) . In some cases, formation of heterodimers of GPCRs has been reported with differences in the pharmacological properties of the receptors in the heterodimer (e.g. GABA B receptor isoforms (11) (12) (13) , ␦ and opiate receptors (14) , dopamine, and somatostatin receptors (10) ).
Further evidence for interaction of GPCRs was provided by Maggio et al. (15) , who created two chimeric receptors ␣ 2 /M 3 and M 3 /␣ 2 , in which the C-terminal regions (transmembrane domains VI and VII) were exchanged between the ␣ 2C adrenergic and M 3 muscarinic receptors. Expression of either chimera alone did not result in any detectable binding of typical radiolabeled muscarinic or adrenergic ligands. However, cotransfection of COS7 cells with both chimeras resulted in the appearance of binding activity corresponding to both native receptors. This has lead to the proposal that some GPCRs might form domain-swapped dimers (16) . Evidence for GPCR interaction in cells has been obtained by expressing GPCRs fused to different chromophores. Transfer of energy between the chromophores has been shown for the ␤ 2 -adrenergic receptor (17) and somatostatin SSTR5 receptor (10) and provides good evidence for the close proximity of the two molecules of GPCRs.
Some radioligand binding studies suggest differences in the number of binding sites labeled by different radioligands. At M 2 muscarinic receptors, the antagonist [ 3 H]QNB labeled twice as many sites as did [ 3 H]AF-DX 384 or N-[ 3 H]methylscopolamine under certain conditions (18) . These data were interpreted in terms of a model where the receptor exists as a tetramer. The D 2 dopamine receptor is of interest in this regard. Several studies suggest that the substituted benzamide radioligand [ 3 H]nemonapride can label more D 2 receptor sites in radioligand binding studies than the butyrophenone [ 3 H]spiperone (3, 19 -21) , although this was not seen in all reports (22, 23) . For D 2 dopamine receptors expressed in recombinant cells, Seeman et al. (21) Malmberg et al. (23) were unable to replicate these findings. Interestingly, Hall et al. (24) found that the number of sites labeled by [ 3 H]raclopride in rat striatal membranes was dependent on the conditions used. [ 3 H]Raclopride labeled more sites in the presence of sodium ions than in their absence. The number of sites labeled by [ 3 H]spiperone was, however, unaffected by sodium ions and was similar to the number of sites labeled by [ 3 H]raclopride in the presence of sodium ions. Theodorou et al. (25) found that another substituted benzamide, [ 3 H]sulpiride, also detected more D 2 receptor binding sites in rat striatum in the presence of sodium ions than it did in their absence, and similar observations have been made for [ 3 H]raclopride binding to the related D 3 dopamine receptor expressed in recombinant cells (26) .
These observations are not consistent with the labeling by these radioligands of single populations of independent D 2 dopamine receptors. They are more consistent with the labeling of oligomeric arrays with different degrees of cooperativity between the monomeric units, depending on assay conditions (18, 27 3 H]raclopride (60 -86 Ci/mmol) was purchased from PerkinElmer Life Sciences. S-(Ϫ)-Sulpiride, haloperidol, and butaclamol were purchased from RBI (Natick, MA). All other materials were obtained from commercial sources and were of the highest available purity.
Cell Growth and Membrane Preparation-CHO cells expressing the human D 2(short) dopamine receptor (28) were grown as monolayers in RPMI medium supplemented with 2 mM glutamine, 200 g/ml active Geneticin, and 5% fetal calf serum at 37°C in a moist, 5% CO 2 atmosphere. Cells were washed with 5 ml of ice-cold buffer A (20 mM HEPES, 1 mM EDTA (free acid) 1 mM EGTA, pH 7.4, with KOH), removed from the flask by gentle shaking with 2-mm diameter glass beads in 5 ml of buffer A, and homogenized with 30 strokes of a Dounce homogenizer. The homogenate was centrifuged at 260 ϫ g for 10 min, and the resulting supernatant centrifuged at 48,000 ϫ g for 1 h at 4°C. The pellet was resuspended in ice-cold buffer A to ϳ5-10 mg/ml, and aliquots were stored at Ϫ70°C. Protein concentration was determined by the method of Lowry et al. (29) .
Saturation Radioligand Binding Experiments-Control experiments were performed in buffer A, while 100 mM NaCl or 100 mM N-methyl-D-glucamine (NMDG) was included in the buffer in order to determine the effects of sodium ions or ionic strength. Total and nonspecific binding were defined in the presence of 3 M (Ϫ)-butaclamol and 3 M (ϩ)-butaclamol, respectively. [
3 H]raclopride saturation binding experiments were performed in a total volume of 0.5 ml using 3-15 g of membrane protein per tube and 10 concentrations of [ 3 H]raclopride typically ranging between 20 pM and 10 nM. [ 3 H]Spiperone saturation binding experiments were performed in total volumes of either 1 or 10 ml, both using 10 -30 g of membrane protein/tube and 10 concentrations of the radioligand, typically between 10 pM and 5 nM for 1-ml saturations, or 16 concentrations between 1 pM and 1 nM for 10-ml experiments. In experiments that included raclopride or haloperidol, the range of [ , by which time the radioligands had reached equilibrium. Experiments were terminated by rapid filtration through Whatman GF/C glass fiber filters using a Brandel cell harvester followed with four washes of 3 ml of ice-cold phosphate-buffered saline (140 mM NaCl, 10 mM KCl, 1.5 mM KH 2 PO 4 , 8 mM Na 2 HPO 4 ). Filter discs were soaked in 2 ml each of Optiphase Hi-Safe 3 (Wallac) for at least 6 h before radioactivity was determined by liquid scintillation spectroscopy.
Inhibition of Equilibrium [ 3 H]Spiperone
Binding-A range of concentrations of the competing ligand were incubated with 10 -30 g of membranes and a fixed concentration of [ 3 H]spiperone in triplicate for 3 h at 25°C before harvesting as described above. Total and nonspecific binding were defined in the presence of 3 M (Ϫ)-butaclamol and 3 M (ϩ)-butaclamol, respectively.
Data Analysis-Data were analyzed using Prizm (GraphPad, San Diego CA). In saturation experiments, specifically and nonspecifically bound [ 3 H]spiperone were calculated from saturation data using the method of Golds et al. (30) , which makes a correction for the depletion of the radioligand. Data were fitted to equations describing one-or two-site binding models, and the best fit was determined using an F-test. Competition experiments were fitted to four-parameter logistic equations, and the best fit between a variable Hill coefficient and a Hill coefficient fixed to unity was determined using an F-test. In the analysis of the competition data, the free radioligand concentration was taken as the added minus total bound in the absence of competitor. The amount bound will be in fact be different at the top and bottom of the competition curve. The total bound was, however, ϳ12 and ϳ1% of the added radioligand in the absence and presence, respectively, of saturating concentrations of competitor ([ 3 H]spiperone, ϳ0.25 nM). The total bound radioligand in the absence of competitor was Ͻ10% for the higher radioligand concentrations used. The effect of this correction on estimates of K i is slight (ϳ5% at 0.25 nM radioligand).
The statistical significance of difference between data was determined at the 0.05 level, using ANOVA A range of raclopride concentrations was included in 1-ml volume [ 3 H]spiperone saturation binding experiments. Analysis of the data according to the method of Schild gave rise to the plot in Fig. 2b . The pA 2 value for raclopride derived from these data was 7.12, corresponding to 76 nM. The pA 2 value predicted from a simple competitive model, using the affinity of [ 3 H]raclopride given in Table I , was 8.97, corresponding to 1.1 nM, a difference of 71-fold from the measured value.
Similar experiments were performed, in the absence of sodium ions or NMDG, using haloperidol as the competing ligand. In the presence of 100 mM NaCl, no significant effect of raclopride on [
3 H]spiperone B max was found (Fig. 4A) . Analysis of the data according to the method of Schild (Fig. 4B ) resulted in a pA 2 value for raclopride in the presence of sodium ions of 8.79 (1.6 nM). This is 6.9-fold greater than the value of 9.63 (0. 3 H]spiperone were also performed in the presence of 100 mM NaCl, yielding a K i of 0.95 nM (9.02 Ϯ 0.05, pK i Ϯ S.E., n ϭ 3) or in the presence of 100 mM NMDG, resulting in a K i of 11.3 nM (7.95 Ϯ 0.08, pK i Ϯ S.E., n ϭ 3). [ 3 H]spiperone binding was inhibited by raclopride to the level of nonspecific binding under both of these conditions.
DISCUSSION
In this study, we have examined the binding of two ligands (raclopride and spiperone) to human D 2(short) dopamine receptors expressed in CHO cells. Saturation and competition experiments have been used to show that the D 2 receptor functions as an oligomer and that the properties of this oligomeric receptor may be modulated by the ionic conditions.
In saturation binding assays, sodium ions were found to exert allosteric effects on [ 3 H]raclopride binding to recombinant human D 2(short) dopamine receptors. The presence of sodium ions was found to increase the affinity of [ 3 H]raclopride for the D 2 receptor, and this phenomenon has been described extensively before for drugs of the substituted benzamide class (25, (32) (33) (34) (35) (36) (37) (38) . In the present study, the dissociation constant decreased from 1.1 nM approximately 5-fold to 0.23 nM. The effect was specific to sodium ions, since the presence of an equal concentration (100 mM) of NMDG as a control for changes in ionic strength had no appreciable effect on the (44), and the mean Ϯ S.E. was determined for each haloperidol concentration. Data plotted above were subjected to linear regression (slope ϭ 1.1), and the pA 2 value was determined as the intercept. f, experimental data, pA 2 3 H]spiperone saturation binding assays reduced the apparent affinity of the radioligand in a concentration-dependent manner, as seen in Fig. 3B . The K d value derived from this analysis was in excellent agreement with values derived using assay conditions defined to avoid artifacts (23, 31, 41) The B max of the radioligand was unaffected by haloperidol, as seen in Fig. 3A . These data are in agreement with a simple competitive model of two ligands competing for a single population of identical binding sites.
In a similar experimental design, raclopride (in the absence of sodium ions) also decreased the apparent affinity of [ 3 H]spiperone, but the observed decrease in affinity was smaller than predicted assuming competitive inhibition and using the K d of raclopride derived from saturation analyses. Similarly, in competition experiments versus [ 3 H]spiperone in the absence of sodium ions, the K i for raclopride implied a lower affinity than suggested from saturation analyses. These differences in estimates of ligand affinity suggest that there is negative cooperativity between the two ligands. In addition, however, raclopride lowered the apparent 3 H]spiperone saturation binding assays were performed in a total volume of 1 ml in the presence of raclopride and 100 mM NaCl as described under "Experimental Procedures." Data were fitted to a one-binding site model, and B max values were determined. Data were expressed as a proportion of the B max determined in the absence of raclopride for each experiment, and the means with S.E. error bars are shown for four experiments at each raclopride concentration. B, Schild plot of raclopride effect on [ 3 H]spiperone affinity in the presence of sodium ions. [ 3 H]spiperone saturation binding assays were performed in a 1-ml volume in the presence of 100 mM NaCl and in the presence of a range of concentrations of raclopride as described under "Experimental Procedures." Data were fitted to a one-binding site model and the K d obtained. Data from each of four experiments were transformed according to the method of Schild (44) , and the mean Ϯ S.E. was determined for each raclopride concentration. Data plotted above were subjected to linear regression, and the pA 2 value was determined as the intercept. f, experimental data, pA 2 (49), and the mean was determined to be 19.5 nM (7.71 Ϯ 0.06, pK i Ϯ S.E., n ϭ 14). raclopride versus [ 3 H]spiperone in the presence of sodium ions, the K i was very similar to the K d derived from saturation analyses. These data show that sodium ions affect the interaction between [ 3 H]spiperone and raclopride at the D 2 dopamine receptor and that the interaction is largely competitive in the presence of sodium ions.
It should be noted that we analyzed some of the data obtained from saturation analyses in the present study using the method of Schild (44) . This method is strictly applicable only when there is no change in the B max of the radioligand. It is, therefore suitable for analyses of the effects of haloperidol (without Na ϩ ) and raclopride (with Na The data described above, particularly those in the absence of sodium ions, cannot be described by a simple competitive model, so other models must be considered. A model in which the D 2 dopamine receptor is able to form a dimeric unit is described under "Appendix," and simulations of the experiments according to the model have been compared with the data. In this model, two receptor monomers are able to interact, providing two identical ligand binding sites per dimer, which allows the binding of one equivalent of a ligand to affect the binding of a second equivalent of the same ligand or of a different ligand in a cooperative manner. In this model, in the presence of sodium ions, the binding of the first and second equivalents of either [ In the absence of sodium ions, the binding of one equivalent of [ 3 H]raclopride to one half of the dimeric receptor exerts a strong negative cooperativity on the binding of the second equivalent such that the affinity of the second site of the dimer for [ 3 H]raclopride is greatly reduced, and little binding at this site is detected for the range of radioligand concentrations used in the present study. The number of sites labeled under the conditions used in Fig. 1 and the analysis of the data according to a single saturation. If it were possible to use an extended range of concentrations of radioligand, then all of the sites would be occupied. The combination of homotropic negative cooperativity between two molecules of raclopride and the heterotropic negative cooperativity between raclopride and spiperone leads to the need for higher concentrations of raclopride (than predicted from simple competition) to prevent [ 3 H]spiperone binding. In the presence of sodium ions, the strength of cooperativity is reduced, and the ligands behave more competitively. These effects are also seen where the same experiment is performed but in a standard competition format where a range of concentrations of raclopride is used to inhibit the binding of [ 3 H]spiperone. In the absence of sodium ions, the K i for raclopride derived from these experiments is higher than the K d derived from saturation analyses, whereas in the presence of sodium ions the K i for raclopride is very similar to the K d derived from saturation analyses.
The simulations of experiments using the model described under "Appendix" are for the most part in good agreement with the data obtained. This indicates that the model (Scheme 1) proposed here provides a first approximation to describing the experimental phenomena described here. An alternative possible model that could explain some of the behavior seen in the present study would be one where raclopride binds to two sets of independent sites of higher and lower affinity in the absence of sodium ions. This might explain some of the experimental observations such as the effects of raclopride on the B max of [ 3 H]spiperone. For such a model, however, if spiperone has equal affinities for the two putative sets of sites, it would be expected that raclopride inhibition of [ 3 H]spiperone binding would be described by inhibition curves with Hill coefficients substantially less than 1. In the present study, raclopride/ [ 3 H]spiperone inhibition curves do not exhibit such behavior, and this observation seems to rule out the "two-site" model.
The data described in the present report can, therefore, be approximated in terms of a scheme in which there are two interacting sites in a dimer for the D 2 dopamine receptor. Some of the observations reported here have been reported for D 2 receptors in the brain (24) so that this phenomenon is not confined to receptors expressed in recombinant cells. The present data complement data obtained on this receptor using protein chemical methods under denaturing conditions, where the existence of dimers was inferred (3). The model may also explain some other phenomena that have been observed for the D 2 dopamine receptor such as the observation of two rates of radioligand dissociation (31, 45) , the complex pH dependence of the binding of some ligands (46) (19, 21) , suggesting that higher order species than dimers may exist. The present data are, however, consistent with homodimers. There are also some similarities between the present observations with the D 2 dopamine receptor and the model proposed by Wreggett and Wells (18) for the muscarinic acetylcholine receptor, suggesting that the observations may have some generality.
APPENDIX

A Model Describing the Interaction of Two Competing Ligands with a Dimeric Receptor
In Scheme 1, R is a divalent receptor oligomer with binding sites for competitive ligands A and B for which equilibrium association constants are K A and K B , respectively. The allosteric constants ␣ and ␤ govern the effect of the presence of a first equivalent of ligand on the formation of a homo-bi-liganded species for ligands A and B, respectively. The constant ␥ governs formation of the hetero-bi-liganded species.
Stoichiometrically equivalent species (e.g. monoliganded species where the ligand is bound to either half of the dimer) are assumed to be functionally indistinguishable so the equilibrium constant is taken as the same. Association constants describing the scheme above are listed in Scheme 2.
The total number of ligand binding sites is twice the number of receptor dimers.
2 ) (Eq.
2)
The amount of ligand B which is bound is defined as follows.
Thus fractional occupancy of ligand binding sites by ligand B is described as follows.
Similarly, for ligand A, fractional occupancy of binding sites is described as follows. 3 H]raclopride was represented by ligand A in the model, and it was assumed that the apparent differential binding capacities for the radioligand were due to the occupancy of approximately one-half of the sites in the dimer in the absence of sodium ions and both sites in the presence of sodium ions for the range of radioligand concentrations used in the experiments described above. In the presence of sodium ions, where the radioligand occupies both sites with a single apparent affinity, the microscopic association constant (K A ) can be equated to the reciprocal of the macroscopic dissociation constant K d (0.23 nM, Table I ). This conclusion may be derived using Equation 6 in the absence of ligand B and with ␣ ϭ 1.
In the absence of sodium ions, the microscopic and macroscopic dissociation constants (K (micro) and K (macro) respectively) for occupancy of the ith site on a protein with n sites (47, 48) are given by Equation 7 .
For the first site of a dimer and substituting K (macro) as the dissociation constant for the radioligand in a ligand binding assay (K d (values in Fig. 1 . The simulations shown have been generated with no competing ligand and with values of ␤ ϭ 1, ␥ ϭ 0.2, and ␣ set to either 1 or 0.015. When ␣ ϭ 1 (with Na ϩ ), the radioligand labels both sites of the dimer, and the maximum number of binding sites are labeled with a single affinity. When ␣ ϭ 0.015 (without Na ϩ ), the radioligand will label both sites of the dimer at high concentrations, but there is some flattening of the saturation curve so that if the range of (Fig. 2) .
The second consideration is that in the absence of sodium ions, inclusion of 10 M raclopride in [ 3 H]spiperone saturation experiments reduced the experimentally measured B max to approximately three-quarters of that determined in the absence of competing ligand (Fig. 2) and increased the apparent K d to ϳ3.5 nM. Intermediate concentrations of raclopride exerted smaller effects. These experimental data can be simulated in the model (Fig. 7) 3 H]spiperone binding corresponds to a single saturation, and raclopride serves to decrease the apparent affinity of the radioligand without altering its B max over the range of radioligand concentrations used in the experiments described here.
The third observation that the model must explain is that raclopride fully inhibits [ 3 H]spiperone binding in competition experiments in both the absence and presence of sodium ions. In the presence of sodium ions, each ligand can bind to both sites of the dimer with equal affinity as described above. Under these conditions, interactions between the two ligands appear competitive. In the absence of sodium ions, the data may be simulated by using the parameters ␣ ϭ 0.015, ␤ ϭ 1, and ␥ ϭ 0.2 and (Fig. 8) . The simulations of the model are in good agreement with the data, although there is some deviation at low concentrations of raclopride.
In the analysis presented above, it has been assumed that sodium ions had no effect on the B max of [ Table I , however, this is an oversimplification in that the B max of this radioligand is sensitive to sodium ions but less so than for [ 3 H]raclopride. It is important to emphasize that, under all experimental conditions, assuming the model presented here, if a wide enough range of radioligand concentrations were used then both sites of the dimer would be occupied. The apparent reduction in the B max for [ 3 H]raclopride in the absence of sodium ions (Table I ) and the apparent reduction in the B max for [ 3 H]spiperone induced by raclopride (Figs. 2 and 7 ) result from the shape of the saturation curves and the range of radioligand concentrations used in the experiments performed. It would be very interesting to determine, for example, the effects of raclopride in [ 3 H]spiperone saturation analyses in the absence of sodium ions with greatly increased concentrations of [ 3 H]spiperone, although this may not be feasible technically.
The examples above indicate that the model is capable of describing the interactions of spiperone and raclopride reported above and that D 2 dopamine receptors may therefore exist as dimers. It is notable that the model presented here is essentially an abbreviation of the tetrameric receptor model described by Wreggett and Wells (18) , in which radioligand binding to the M 2 muscarinic acetylcholine receptor was found to be consistent with the receptor forming tetrameric oligomers. with [ 3 H]AFDX could be described by a dimeric model, while data with [ 3 H]NMS required at least a trimer, but data with all three radioligands required the assumption of at least a tetrameric arrangement. It is possible then that the D 2 dopamine receptor could exist as higher order oligomers, but a dimer is sufficient to describe the data presented here. Use of other radioligands and immunological techniques would be required to demonstrate the existence of dopamine receptor oligomers.
